COVID-19 Vaccines Not Linked to Miscarriage in Surveillance Study
Experts discuss emerging safety data on administration of COVID-19 mRNA vaccines during pregnancy.
Experts discuss emerging safety data on administration of COVID-19 mRNA vaccines during pregnancy.
New data out of Israel could bolster the notion that a third booster shot of the COVID-19 vaccine significantly lowers a recipient’s odds for severe illness.
Before authorization of the COVID-19 vaccine, vaccine hesitancy was increased among Black, Hispanic or Latino, and Asian HCWs compared with White HCWs.
A new algorithm offers guidance on when to start and stop noninvasive respiratory therapies for COVID-19.
The Centers for Disease Control and Prevention continues to recommend COVID-19 vaccination for all individuals 12 years of age and older.
Moderna Inc. announced Wednesday that it has completed its submission for full approval of its COVID-19 vaccine.
The majority of individuals who experience mild or moderate COVID-19 infection have persistent symptoms more than 30 days after diagnosis.
A decision on booster shots for the approximately 13.8 million Americans who received the Johnson & Johnson single-shot COVID-19 vaccine is likely to take weeks.
Vaccination protects against SARS-CoV-2 infection and hospitalization during a period with increasing predominance of the delta variant.
The vaccine effectiveness against SARS-CoV-2 infection decreased to 66 percent when the delta variant became predominant.